Back to Journals » Vascular Health and Risk Management » Volume 8

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Total article views   Abstract views HTML views PDF downloads Totals
12,750 Dovepress* 8,410 568+ 2,516 8,978
PubMed Central* 6 3,766 1,639 3,772
Totals 8,416 4,334 4,155 12,750
*Since 11 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar